Non-communicable diseases (NCDs) are the cause of more than 70% of deaths worldwide. As the COVID-19 pandemic continues, high-risk patients – particularly those with pre-existing conditions like heart disease – make the prevention and control of NCDs more important than ever.

In an effort to raise awareness of the global public health impact of NCDs, the ACC is partnering this week with the World Heart Federation (WHF), NCD Alliance (NCDA) and Pfizer Upjohn for a Week of Action dedicated to raising awareness around the burden of NCDs worldwide.

The Week of Action, which kicked off yesterday, will celebrate the launch of ACC's NCD Academy. Developed in partnership with WHF and NCDA and with support from Pfizer Upjohn, NCD Academy equips primary care providers with a free mobile app featuring a suite of online certificate programs to enhance, refresh and showcase their knowledge of techniques and therapies for NCD prevention and screening. The first course will focus on cardiovascular disease and stroke and additional courses in cancer, chronic respiratory diseases, diabetes and mental disorders will be launched in the future. Learn more about the NCD Academy.

The ACC is also highlighting the success to date of its Global Prevention Program, created in 2016 through a partnership with Pfizer, that provides clinicians worldwide with the latest science, technology, resources and tools needed to stem the rising tide of cardiovascular disease and reinforce best practices in treating patients. Since its launch, the program has hosted 44 webinars, reaching more than 70,000 clinicians and an estimated 230 million patients across nine countries. Read the full Global Prevention Program Report.

ACC leaders are encouraged to follow @ACCinTouch on Twitter and share posts and join discussions using #NCDs and #NCDAcademy.

Clinical Topics: COVID-19 Hub

Keywords: ACC International, Cardiovascular Diseases, Public Health, COVID-19, Social Media, severe acute respiratory syndrome coronavirus 2

< Back to Listings